Skip to the content
logo mainlogo darklogo light
hello@pharmet.io
0

No products in the cart.

  • Home
  • About Us
  • Why Pharmet
  • Products
  • Certifications
  • Customization
  • Faq’s
  • Blogs
  • Contact Us
Contact us
logo main
0

No products in the cart.

  • Home
  • About Us
  • Why Pharmet
  • Products
  • Certifications
  • Customization
  • Faq’s
  • Blogs
  • Contact Us
HomeShopHormonal Therapy ProductMedroxyprogesterone Acetate Injection 150 MG/ML
Logo
Medroxyprogesterone Acetate Injection 150 MG/ML
Categories:Hormonal Therapy Product, Progestin Therapy SKU: 00001-46
Medroxyprogesterone Acetate Injection 150 MG/ML

Download as PDF
Enquire Now
Add to Compare
  • Description
  • Reviews (0)

Description

PRODUCT DESCRIPTION:

 

Medroxyprogesterone Acetate is a long-acting progestin widely used in reproductive health for contraception and in the management of various hormone-sensitive conditions.

The 150 MG/ML depot formulation is designed for intramuscular injection every 3 months, providing a reliable and reversible form of birth control.

This formulation is also used in specific gynecological disorders, endometriosis, and adjunctively in hormone-responsive cancers under specialist supervision. Manufactured in GMP-certified facilities, it offers high purity, prolonged action, and consistent clinical performance.

Formulation & Presentation:

  • Dosage Form: Injectable Solution
  • Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
  • Available Strengths: 150 MG/ML
  • Route of Administration: Intramuscular Only (IM) or as per clinical indication and severity (As per physician’s discretion or decision)

Therapeutic Indications:

  • Long-acting contraception for women
  • Management of endometriosis-related pain
  • Treatment of secondary amenorrhea
  • Adjunct therapy in endometrial or renal carcinoma (where clinically indicated)

Side Effects:

  • COMMON:
    • Weight gain
    • Menstrual irregularities or delayed return to fertility
    • Headache
    • Breast tenderness
  • SERIOUS (RARE):
    • Decreased bone mineral density with long-term use
    • Mood disorders or depression
    • Allergic reactions
    • Thromboembolic events (extremely rare)
  • PRECAUTIONS:
    • Not recommended for women with active thromboembolic disorders or hormone-sensitive malignancies (unless under specialist guidance)
    • Prolonged use may affect bone density; consider DEXA scan monitoring
    • Not recommended as first-line therapy in adolescents for contraception due to bone health concerns
    • Should be administered under medical supervision with clear counseling on delayed return to fertility

Reviews

There are no reviews yet.

Be the first to review “Medroxyprogesterone Acetate Injection 150 MG/ML” Cancel reply

Your email address will not be published. Required fields are marked *

12345

TECHNICAL INFORMATION

Product Specifications:

  • HSN Code: To be assigned per international classification standards & import jurisdiction
  • Weight: Approx. 40g per Carton (With Packaging)
  • Dimensions: (15x1x8 CMS)
  • Shelf Life (Subject To Country Specific Guidelines): 2 to 3 years under recommended storage conditions from date of manufacture or as per label specifications
  • Storage: Oil-based injectable solution requiring cold-chain logistics (if specified by packaging). Protect from moisture and direct sunlight. The solution should be used strictly as per label guidelines.

Regulatory Status & Supply Information:

  • Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
  • Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
  • Stability: Compliant
  • MOQ: Negotiable. Based on market & registration status
  • Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

  • Medroxyprogesterone Acetate Injection 150 MG/ML is ideal for public health departments, family planning programs, government tenders, NGOs, and women’s health clinics focused on accessible, long-acting contraceptive options.
  • It is particularly relevant in Africa, Southeast Asia, Latin America, and other regions where injectable birth control is preferred for population-level reproductive health strategies.

Why Source from PHARMET?

  • Single-window sourcing for diverse pharma needs
  • Export-ready documentation & regulatory support
  • Adaptable documentation support for effective registration
  • Trusted consortium network, simplifying India’s complex pharma supply chain
  • Multiple approved manufacturers for best fit in import country
  • Network of audited, compliant manufacturers across India
  • Customizable & flexible branding, packaging & formulation options
  • End-to-end logistics flexibility & support
  • Deep expertise in exporting specialty injectables & all products

CONTACT DETAILS:

  • E-MAIL: hello@pharmet.io
  • Phone/WhatsApp Number: +91 9999091881
  • Website: www.pharmet.io

Related items

  • NORETHISTERONE SUSTAINED RELEASE 5 MG TABLETS
    Quick View
    Add to Compare
    NORETHISTERONE SUSTAINED RELEASE 5 MG TABLETS Read more
  • ESTRADIOL VALERATE
    Quick View
    Add to Compare
    ESTRADIOL VALERATE Read more
  • Dexamethasone Injection 4 MG/ML
    Quick View
    Add to Compare
    Dexamethasone Injection 4 MG/ML Read more
  • ESTRADIOLE + DYDROGESTERONE TABLETS
    Quick View
    Add to Compare
    ESTRADIOLE + DYDROGESTERONE TABLETS Read more
Quick Links
  • Home
  • About Us
  • Why Pharmet?
  • Contact Us
Browse More
  • Products
  • Certifications
  • Customization
Working Hours

Mon - Fri: 09:00 - 18:00

Sat: 09:30 - 14:00

Sun: Closed

Follow us

hello@pharmet.io
+91 9999091881
PHARMET GLOBAL, DELHI
Pharmet.io, 2025
  • Log in
  • Sign up
  • Reset Password
Lost Your password?








    Complete your Request For Quotation (RFQ)

      WhatsApp us

      Newsletter Signup

      Subscribe to receive updates on high-quality pharmaceutical exports, new product lines, and bulk supply deals.

      Enter your email address

      Thanks, I’m not interested